Noticias & Eventos

EOSAL, A NEW PROCEDURE FOR CNVs DETECTION. NEW ALTERNATIVE ANALYSIS METHOD VERSUS MLPA.

We developed EOSAL-CNV, a new method based on proportional amplification and labeling of amplicons in 1 PCR.


The EOSAL-CNV procedure allowed reliable CNV detection by a single PCR and fragment analysis in a capillary DNA sequencer. The results,  published in Clinical Chemistry,show that EOSAL-CNV represents an excellent alternative for CNV detection and characterization or validation in genetic studies and can be incorporated into routine CNV screening in genetic studies for detection and results verification. 
EOSAL was used for the following genes: BRCA1, BRCA2, CHEK2, MLH1, MSH6, MSH2, EPCAM and TP53 gene.









Seqplexing

Seqplexing

Empresa biotecnológica. Desarrollo de test genéticos aplicables en clónica e investigación. Sequencing Multiplex S.L. pretende facilitar la realización de estudios genéticos con propuestas de un alto componente biotecnológico y un elevado valor añadido, de manera que se simplifiquen los procedimientos, permitan reducir los tiempos de obtención e interpretación de resultados con la máxima fiabilidad